Natriumklorid Baxter 9 mg/ ml Νορβηγία - Νορβηγικά - Statens legemiddelverk

natriumklorid baxter 9 mg/ ml

baxter medical ab - natriumklorid - infusjonsvæske, oppløsning - 9 mg/ ml

Natriumklorid Evolan 500 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

natriumklorid evolan 500 mg

evolan pharma ab - natriumklorid - kapsel, hard - 500 mg

Natriumklorid Abboxia 500 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

natriumklorid abboxia 500 mg

abboxia ab - natriumklorid - tablett, filmdrasjert - 500 mg

Prismasol 4 mmol/l Kalium Νορβηγία - Νορβηγικά - Statens legemiddelverk

prismasol 4 mmol/l kalium

baxter holding b.v. - kalsiumkloriddihydrat / magnesiumkloridheksahydrat / glukosemonohydrat / melkesyre, (s)- / natriumklorid / kaliumklorid / natriumhydrogenkarbonat - hemodialyse-/hemofiltreringsvæske

Insulin aspart Sanofi Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - sukkersyke - legemidler som brukes i diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Centyl med kaliumklorid 2.5 mg / 573 mg Νορβηγία - Νορβηγικά - Statens legemiddelverk

centyl med kaliumklorid 2.5 mg / 573 mg

karo pharma ab (1) - bendroflumetiazid / kaliumklorid - tablett, filmdrasjert - 2.5 mg / 573 mg

Sitagliptin / Metformin hydrochloride Accord Ευρωπαϊκή Ένωση - Νορβηγικά - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

bicaVera 1,5 % glukose, 1,25 mmol/l kalsium Νορβηγία - Νορβηγικά - Statens legemiddelverk

bicavera 1,5 % glukose, 1,25 mmol/l kalsium

fresenius medical care deutschland gmbh - kalsiumkloriddihydrat / glukosemonohydrat / magnesiumkloridheksahydrat / natriumklorid / natriumhydrogenkarbonat - peritonealdialysevæske

bicaVera 2,3 % glukose, 1,25 mmol/l kalsium Νορβηγία - Νορβηγικά - Statens legemiddelverk

bicavera 2,3 % glukose, 1,25 mmol/l kalsium

fresenius medical care deutschland gmbh - kalsiumkloriddihydrat / glukosemonohydrat / magnesiumkloridheksahydrat / natriumklorid / natriumhydrogenkarbonat - peritonealdialysevæske

bicaVera 4,25 % glukose, 1,25 mmol/l kalsium Νορβηγία - Νορβηγικά - Statens legemiddelverk

bicavera 4,25 % glukose, 1,25 mmol/l kalsium

fresenius medical care deutschland gmbh - kalsiumkloriddihydrat / glukosemonohydrat / magnesiumkloridheksahydrat / natriumklorid / natriumhydrogenkarbonat - peritonealdialysevæske